NCT04130854 2026-01-28
INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer
University of Texas Southwestern Medical Center
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT04495257 2025-10-30
A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)
Yale University
Phase 1 Active not recruiting
NCT03719430 2025-04-29
APX005M and Doxorubicin in Advanced Sarcoma
Columbia University
Phase 2 Active not recruiting